Influence of the papiliocin peptide derived from Papilio xuthus on the perturbation of fungal cell membranes

FEMS Microbiology Letters

Volumn 311, Issue 1, 2010, Pages 70-75

  Lee, Juneyoung ^a   Hwang, Jae Sam ^b   Hwang, Bomi ^a   Kim, Jin Kyoung ^c   Kim, Seong Ryul ^b   Kim, Yangmee ^c   Lee, Dong Gun ^a  

^a Kyungpook National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

antifungal peptide; membrane active mechanism; papiliocin

Indexed keywords

ANTIFUNGAL AGENT; CALCEIN; PAPILIOCIN; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIFUNGAL ACTIVITY; ARTICLE; BUTTERFLY; CANDIDA ALBICANS; DRUG ISOLATION; FLOW CYTOMETRY; FUNGICIDAL ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; MEMBRANE DAMAGE; MOLECULAR WEIGHT; NONHUMAN; PAPILIO XUTHUS; PEPTIDE SYNTHESIS; PHASE CONTRAST MICROSCOPE; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIFUNGAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BUTTERFLIES; CANDIDA ALBICANS; CELL MEMBRANE; MOLECULAR SEQUENCE DATA;

CANDIDA ALBICANS; PAPILIO XUTHUS; PAPILIONIDAE;

EID: 77956417775     PISSN: 03781097     EISSN: 15746968     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2010.02073.x     Document Type: Article

References (32)

1. Andreu D Rivas L (1998) Animal antimicrobial peptides: an overview. Biopolymers 47 : 415 433.
2. Angelova MI Dimitrov DS (1986) Liposome electroformation. Faraday Discuss Chem Soc 81 : 303 311.
3. Angelova MI, Sloeau S, Meleard P, Faucon JF Bothorel P (1992) Preparation of giant vesicles by external fields. Kinetics and application. Prog Coll Pol Sci 89 : 127 131.
4. Boman HG (1995) Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13 : 61 92.
5. Calderone RA Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9 : 327 335.
6. Cevce G (1993) Lipid properties as a basis for membrane modeling and rational liposome design. Liposome Technology (Gregoriadis G, ed), pp. 1 36. CRC Press, Boca Raton.
7. Dempsey CE (1990) The actions of melittin on membranes. BBA-Biomembranes 1031 : 143 161.
8. Groll AH, Piscitelli SC Walsh TJ (1998) Clinical pharmacology of systemic antifungal agents: a comprehensive review of agents in clinical use, current investigational compounds, and putative targets for antifungal drug development. Adv Pharmacol 44 : 343 500.
9. Habermann E (1972) Bee and wasp venoms. Science 177 : 314 322.
10. Hancock RE, Brown KL Mookherjee N (2006) Host defence peptides from invertebrates - emerging antimicrobial strategies. Immunobiology 211 : 315 322.
11. Hwang PM Vogel HJ (1998) Structure-function relationships of antimicrobial peptides. Biochem Cell Biol 76 : 235 246.
12. Jahn B, Martin E, Stueben A Bhakdi S (1995) Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. J Clin Microbiol 33 : 661 667.
13. Kim SR, Hong MY, Park SW, Choi KH, Yun EY, Goo TW, Kang SW, Suh HJ, Kim I Hwang JS (2010) Characterization and cDNA cloning of a cecropin-like antimicrobial peptide, Papiliocin from the swallowtail butterfly, Papilio xuthus. Mol Cells 29 : 419 423.
14. Klepser ME, Ernst EJ, Lewis RE, Ernst ME Pfaller MA (1998) Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Ch 42 : 1207 1212.
15. Klepser ME, Malone D, Lewis RE, Ernst EJ Pfaller MA (2000) Evaluation of voriconazole pharmacodynamics using time-kill methodology. Antimicrob Agents Ch 44 : 1917 1920.
16. Lee J Lee DG (2009) Antifungal properties of a peptide derived from the signal peptide of the HIV-1 regulatory protein, Rev. FEBS Lett 583 : 1544 1547.
17. Lewis RE (2007) Pharmacodynamic implications for use of antifungal agents. Curr Opin Pharmacol 7 : 491 497.
18. Makovitzki A Shai Y (2005) pH-dependent antifungal lipopeptides and their plausible mode of action. Biochemistry 44 : 9775 9784.
19. Makovitzki A, Avrahami D Shai Y (2006) Ultrashort antibacterial and antifungal lipopeptides. P Natl Acad Sci USA 103 : 15997 16002.
20. Matsuzaki K (2009) Control of cell selectivity of antimicrobial peptides. BBA-Biomembranes 1788 : 1687 1692.
21. Merrifield B (1986) Solid phase synthesis. Science 232 : 341 347.
22. Oliveira CA, Machado AE Pessine FB (2005) Preparation of 100 nm diameter unilamellar vesicles containing zinc phthalocyanine and cholesterol for use in photodynamic therapy. Chem Phys Lipids 133 : 69 78.
23. Park C Lee DG (2009) Fungicidal effect of antimicrobial peptide arenicin-1. BBA-Biomembranes 1788 : 1790 1796.
24. Park SC, Kim MH, Hossain MA, Shin SY, Kim Y, Stella L, Wade JD, Park Y Hahm KS (2008) Amphipathic alpha-helical peptide, HP (2-20), and its analogues derived from Helicobacter pylori: pore formation mechanism in various lipid compositions. BBA-Biomembranes 1778 : 229 241.
25. Pina-Vaz C, Sansonetty F, Rodrigues AG, Costa-Oliveira S, Tavares C Martinez-de-Oliveira J (2001) Cytometric approach for a rapid evaluation of susceptibility of Candida strains to antifungals. Clin Microbiol Infec 7 : 609 618.
26. Selsted ME Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6 : 551 557.
27. Sheppard R (2003) The fluorenylmethoxycarbonyl group in solid phase synthesis. J Pept Sci 9 : 545 552.
28. Spyr CA, Käsermann F Kempf C (1995) Identification of the pore forming element of Semliki Forest virus spikes. FEBS Lett 375 : 134 136.
29. Suzuki T, Fujikura K, Higashiyama T Takata K (1997) DNA staining for fluorescence and laser confocal microscopy. J Histochem Cytochem 45 : 49 53. (Pubitemid 27045364)
30. Tosteson MT, Holmes SJ, Razin M Tosteson DC (1985) Melittin lysis of red cells. J Membrane Biol 87 : 35 44.
31. Wesołowska O, Michalak K, Maniewska J Hendrich AB (2009) Giant unilamellar vesicles - a perfect tool to visualize phase separation and lipid rafts in model systems. Acta Biochim Pol 56 : 33 39.
32. Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415 : 389 395.